Dyadic International
Noelia Valbuena Crespo has a strong background in research and development, with a focus on cell cycle control and regulation in various model organisms. With experience in genetic analysis and supervision of PhD students, Noelia has worked in a range of positions from Senior Scientist to Project Leader. Currently serving as the Director of R&D at Dyadic International, Inc., Noelia's expertise spans both yeast and mammal cells, showcasing a diverse skill set in the field of biotechnology.
This person is not in any offices
Dyadic International
Dyadic International, Inc. (OTCQX: DYAI) is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.